Key result
Intravenous fluid therapy in pre-eclampsia requires careful individual assessment and restrictive management to prevent iatrogenic pulmonary edema, as adequate randomized studies are lacking.
Intravenous fluid therapy in pre-eclampsia requires careful titration and monitoring to balance the need for volume expansion against the high risk of iatrogenic pulmonary oedema.
Supports cautious individualized fluid management in pre-eclampsia; leaves open optimal protocols pending RCTs.
Intravenous fluid given to women with pre-eclampsia may be a necessary form of treatment; however, intravenous fluid therapy can also cause iatrogenic pulmonary oedema. The indications for the use of intravenous fluids, the titration of the amount of fluid given and the use of invasive monitoring have not been subject to adequate examination in randomised studies. Clinical experience, combined with available evidence and a reasoned approach are the basis for a suggested management algorithm.
No takes yet. Share an insight, caveat, or question.
Anthony et al. (2013) conducted a review in Pre-eclampsia. Intravenous fluid management was evaluated. Intravenous fluid therapy in pre-eclampsia requires careful individual assessment and restrictive management to prevent iatrogenic pulmonary edema, as adequate randomized studies are lacking.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: